BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25234543)

  • 1. Leukocyte-specific protein 1: a novel regulator of hepatocellular proliferation and migration deleted in human hepatocellular carcinoma.
    Koral K; Paranjpe S; Bowen WC; Mars W; Luo J; Michalopoulos GK
    Hepatology; 2015 Feb; 61(2):537-47. PubMed ID: 25234543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte-Specific Protein-1 Controls Sorafenib Sensitivity and Hepatocellular Proliferation through Extracellular Signal-Regulated Kinase 1/2 Activation.
    Koral K; Haynes M; Bowen WC; Orr A; Mars W; Michalopoulos GK
    Am J Pathol; 2018 Sep; 188(9):2074-2086. PubMed ID: 30126548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte-Specific Protein-1 Suppresses Xenobiotic-Induced Constitutive Androstane Receptor and Subsequent Yes-Associated Protein-Activated Hepatocyte Proliferation.
    Koral K; Bhushan B; Orr A; Stoops J; Bowen WC; Copeland MA; Locker J; Mars WM; Michalopoulos GK
    Am J Pathol; 2022 Jun; 192(6):887-903. PubMed ID: 35390317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton.
    Harrison RE; Sikorski BA; Jongstra J
    J Cell Sci; 2004 Apr; 117(Pt 10):2151-7. PubMed ID: 15090600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes.
    Vacca M; Murzilli S; Salvatore L; Di Tullio G; D'Orazio A; Lo Sasso G; Graziano G; Pinzani M; Chieppa M; Mariani-Costantini R; Palasciano G; Moschetta A
    Gastroenterology; 2013 Jun; 144(7):1518-1529.e3. PubMed ID: 23462179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
    Zhang S; Nguyen LH; Zhou K; Tu HC; Sehgal A; Nassour I; Li L; Gopal P; Goodman J; Singal AG; Yopp A; Zhang Y; Siegwart DJ; Zhu H
    Gastroenterology; 2018 Apr; 154(5):1421-1434. PubMed ID: 29274368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hepatic progenitor cells on experimental hepatocellular carcinoma in the regenerating liver.
    Shi JH; Scholz H; Huitfeldt HS; Line PD
    Scand J Gastroenterol; 2014 Jan; 49(1):99-108. PubMed ID: 24188385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Hepatocellular Carcinomas Following Chronic Liver Injury.
    Lin YH; Zhang S; Zhu M; Lu T; Chen K; Wen Z; Wang S; Xiao G; Luo D; Jia Y; Li L; MacConmara M; Hoshida Y; Singal AG; Yopp A; Wang T; Zhu H
    Gastroenterology; 2020 May; 158(6):1698-1712.e14. PubMed ID: 31972235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma.
    Reschke M; Ferby I; Stepniak E; Seitzer N; Horst D; Wagner EF; Ullrich A
    Hepatology; 2010 Apr; 51(4):1383-90. PubMed ID: 20044804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis.
    Donthamsetty S; Bhave VS; Mars WM; Bowen WC; Orr A; Haynes MM; Wu C; Michalopoulos GK
    PLoS One; 2013; 8(9):e74625. PubMed ID: 24058607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
    Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
    J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-specific over-expression of Cripto-1 in transgenic mice promotes hepatocyte proliferation and deregulated expression of hepatocarcinogenesis-related genes and signaling pathways.
    Liu Y; Li YQ; Huang SH; Li YL; Xia JW; Jia JS; Wei F; Wang JH; Dai GQ; Wang YC; Li XY; Han LX; Zhang XL; Xiang XD; Zhao WT; Xiao D; Lin XL
    Aging (Albany NY); 2021 Sep; 13(17):21155-21190. PubMed ID: 34517344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.
    Hui L; Zatloukal K; Scheuch H; Stepniak E; Wagner EF
    J Clin Invest; 2008 Dec; 118(12):3943-53. PubMed ID: 19033664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
    Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells.
    Zhang HJ; Yao DF; Yao M; Huang H; Wang L; Yan MJ; Yan XD; Gu X; Wu W; Lu SL
    World J Gastroenterol; 2013 Jun; 19(24):3792-801. PubMed ID: 23840117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.
    Baek HJ; Lim SC; Kitisin K; Jogunoori W; Tang Y; Marshall MB; Mishra B; Kim TH; Cho KH; Kim SS; Mishra L
    Hepatology; 2008 Oct; 48(4):1128-37. PubMed ID: 18704924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation.
    D'Souza AM; Jiang Y; Cast A; Valanejad L; Wright M; Lewis K; Kumbaji M; Shah S; Smithrud D; Karns R; Shin S; Timchenko N
    Cell Mol Gastroenterol Hepatol; 2018; 6(3):239-255. PubMed ID: 30109252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3.
    Zhang J; Huang JZ; Zhang YQ; Zhang X; Zhao LY; Li CG; Zhou YF; Wei H; Yu J
    EBioMedicine; 2020 Mar; 53():102701. PubMed ID: 32151798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.